Evaxion Biotech-arkiv - BioStock

Expres2ion to raise SEK 60 million

Rights issue takes Expres2ion breast cancer vaccine to phase I

14 June, 2024

Evaxion_CancerVaccine_Concept

Evaxion to develop novel precision cancer vaccine concept

31 January, 2024

Evaxion unveils refined business strategy

Evaxion unveils refined business strategy

21 December, 2023

Evaxion bacterial vaccine partnerships

Evaxion establishes two Big Pharma partnerships

26 September, 2023

Evaxion summer milestones

Evaxion reaches key milestones during summer

24 August, 2023

Per Norlén, CEO Evaxion

Evaxion brings in Per Norlén as CEO

21 October, 2022

Evaxion receives NIH grant for gonorrhoea vaccine

14 September, 2022

Evaxion Biotech publishes EVX-01 data in scientific journal

Evaxion Biotech publishes EVX-01 data in scientific journal OncoImmunology

9 February, 2022